Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X:
“VOLGA: OS benefit without adjuvant EV. Do we really need EV after surgery?
An important question for future trials.
Proud to have contributed to this study.”
You can also read: VOLGA at ESMO 2026: Perioperative Durvalumab With or Without Tremelimumab Plus Enfortumab Vedotin in MIBC
